News
GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...
Instant ramen maker Nissin Foods is leveraging the buzz around GLP-1s to launch in the US a trio of decadent tasting frozen ...
Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for ...
A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...
Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results